MYOTONIC DYSTROPHY 1
Clinical trials for MYOTONIC DYSTROPHY 1 explained in plain language.
Never miss a new study
Get alerted when new MYOTONIC DYSTROPHY 1 trials appear
Sign up with your email to follow new studies for MYOTONIC DYSTROPHY 1, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug aims to ease muscle stiffness in rare disease
Disease control OngoingThis phase 3 study tests an experimental drug called AOC 1001 for myotonic dystrophy type 1, a genetic condition that causes muscle weakness and stiffness. About 159 adults who can walk independently are receiving either the drug or a placebo to see if it improves hand function, …
Matched conditions: MYOTONIC DYSTROPHY 1
Phase: PHASE3 • Sponsor: Avidity Biosciences, Inc. • Aim: Disease control
Last updated May 26, 2026 07:35 UTC
-
New hope for DM1: Long-Term trial of AOC 1001 begins
Disease control ENROLLING_BY_INVITATIONThis study is for people with myotonic dystrophy type 1 (DM1) who have already taken part in earlier AOC 1001 trials. It aims to see if the drug is safe and works well over a longer period. About 230 adults will receive the medicine by IV and be monitored for side effects and ben…
Matched conditions: MYOTONIC DYSTROPHY 1
Phase: PHASE3 • Sponsor: Avidity Biosciences, Inc. • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
500 chinese patients join landmark DM1 genetic study
Knowledge-focused ENROLLING_BY_INVITATIONThis study aims to collect health and genetic information from 500 Chinese adults with myotonic dystrophy type 1 (DM1), a muscle-weakening disease. Researchers will measure walking speed and daytime sleepiness to see how the condition affects daily life. The goal is to learn more…
Matched conditions: MYOTONIC DYSTROPHY 1
Sponsor: Huashan Hospital • Aim: Knowledge-focused
Last updated May 26, 2026 07:25 UTC